PT Lotte Chemical Titan Tbk
IDX:FPNI.JK
200 (IDR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 376.213 | 473.879 | 412.096 | 309.367 | 331.945 | 433.868 | 433.346 | 441.825 | 457.333 | 621.731 | 586.375 | 570.089 | 537.237 | 428.359 | 389.811 |
Cost of Revenue
| 369.78 | 459.389 | 388.501 | 307.424 | 327.389 | 415.763 | 426.548 | 428.326 | 439.514 | 613.802 | 577.09 | 562.139 | 531.133 | 429.689 | 340.513 |
Gross Profit
| 6.433 | 14.49 | 23.595 | 1.943 | 4.556 | 18.105 | 6.798 | 13.499 | 17.819 | 7.929 | 9.285 | 7.95 | 6.104 | -1.33 | 49.298 |
Gross Profit Ratio
| 0.017 | 0.031 | 0.057 | 0.006 | 0.014 | 0.042 | 0.016 | 0.031 | 0.039 | 0.013 | 0.016 | 0.014 | 0.011 | -0.003 | 0.126 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1.088 | 1.061 | 0.81 | 0.861 | 0.925 | 0.855 | 0.913 | 4.06 | 0.92 | 1.536 | -0.419 | 2.864 | 6.301 | 7.958 | 5.506 |
Selling & Marketing Expenses
| 6.601 | 7.428 | 9.123 | 5.952 | 5.411 | 4.825 | 5.175 | 5.367 | 5.809 | 7.424 | 7.315 | 7.535 | 7.72 | 6.974 | 9.268 |
SG&A
| 7.689 | 8.489 | 9.933 | 6.813 | 6.336 | 5.68 | 6.088 | 9.427 | 6.729 | 8.96 | 6.896 | 10.399 | 14.021 | 14.932 | 14.774 |
Other Expenses
| 2.479 | 3.678 | 4.415 | 4.103 | 3.845 | 0.71 | 0.803 | 0.72 | 0.477 | 0.644 | 0.637 | 0.921 | 0 | 7.208 | 7.208 |
Operating Expenses
| 11.661 | 12.167 | 14.348 | 10.916 | 10.181 | 9.153 | 9.677 | 9.427 | 9.818 | 11.631 | 9.659 | 13.648 | 14.021 | 22.14 | 21.982 |
Operating Income
| -1.104 | 3.239 | 12.325 | -7.724 | -4.281 | 8.952 | -2.879 | 4.072 | 8.478 | -3.058 | -2.373 | -5.698 | -7.917 | -23.47 | 27.316 |
Operating Income Ratio
| -0.003 | 0.007 | 0.03 | -0.025 | -0.013 | 0.021 | -0.007 | 0.009 | 0.019 | -0.005 | -0.004 | -0.01 | -0.015 | -0.055 | 0.07 |
Total Other Income Expenses Net
| -0.036 | -0.092 | -0.093 | -0.101 | -0.052 | -0.39 | 0.673 | 0.317 | -1.39 | -1.414 | -4.431 | -3.603 | -3.07 | -1.929 | -3.593 |
Income Before Tax
| -1.14 | 3.147 | 12.232 | -7.825 | -4.333 | 8.562 | -2.206 | 4.389 | 7.088 | -4.472 | -6.804 | -9.301 | -10.987 | -25.399 | 23.723 |
Income Before Tax Ratio
| -0.003 | 0.007 | 0.03 | -0.025 | -0.013 | 0.02 | -0.005 | 0.01 | 0.015 | -0.007 | -0.012 | -0.016 | -0.02 | -0.059 | 0.061 |
Income Tax Expense
| -0.74 | 0.251 | 2.668 | -2.88 | -1.047 | 2.437 | -0.46 | 2.22 | 4.108 | 1.97 | -0.654 | 7.173 | 0.758 | -2.59 | -4.722 |
Net Income
| -0.399 | 2.892 | 9.55 | -4.945 | -3.286 | 6.125 | -1.746 | 2.169 | 2.98 | -6.442 | -6.15 | -16.474 | -12.804 | -22.809 | 28.445 |
Net Income Ratio
| -0.001 | 0.006 | 0.023 | -0.016 | -0.01 | 0.014 | -0.004 | 0.005 | 0.007 | -0.01 | -0.01 | -0.029 | -0.024 | -0.053 | 0.073 |
EPS
| -0 | 0.001 | 0.002 | -0.001 | -0.001 | 0.001 | -0 | 0 | 0.001 | -0.001 | -0.001 | -0.003 | -0.002 | -0.004 | 0.005 |
EPS Diluted
| -0 | 0.001 | 0.002 | -0.001 | -0.001 | 0.001 | -0 | 0 | 0.001 | -0.001 | -0.001 | -0.003 | -0.002 | -0.004 | 0.005 |
EBITDA
| -0.547 | 3.765 | 12.853 | -7.15 | -4.077 | 8.785 | -1.788 | 4.389 | 9.365 | -2.686 | 2.583 | -5.894 | -9.649 | -16.643 | 31.498 |
EBITDA Ratio
| -0.001 | 0.008 | 0.031 | -0.023 | -0.012 | 0.02 | -0.004 | 0.01 | 0.02 | -0.004 | 0.004 | -0.01 | -0.018 | -0.039 | 0.081 |